Mitsubishi Pharma Sign Agreement on 2D Gel Image Analysis
News May 24, 2006
Mitsubishi Pharma Corporation has contracted Ludesi for image analysis of twodimensional protein gels (2D gels), one of the fundamental technologies in proteomics.
"We are proud that Mitsubishi Pharma has selected Ludesi’s technology for 2D gel image analysis, and we look forward to working together in the years to come," commented Ludesi’s CEO Ola Forsstrom-Olsson.
"It is an honor to serve Mitsubishi Pharma’s skilled scientists with top-notch quality in this important proteomics technology."
Experts at Mitsubishi Pharma Corporation tested Ludesi’s system thoroughly and concluded that Ludesi’s offering provided an increased quality and reliability compared to other software systems on the market.
‘Good Cholesterol’ May Not Always be Good for Postmenopausal WomenNews
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) – also known as ‘good cholesterol’ – according to a study led by researchers in the University of Pittsburgh Graduate School of Public Health.READ MORE
What Makes Good Brain Proteins Turn Bad?News
The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.